US 11952344
Heterocyclic compound and use thereof
granted A61PA61P25/00A61P29/00
Quick answer
US patent 11952344 (Heterocyclic compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P25/00, A61P29/00